Skip to content

References

We love to keep things simple – like our therapy.
That’s why you can find all our references here.

  1. Siminiak T, et. al. Treatment of functional mitral regurgitation by percutaneous annuloplasty: Results of the TITAN Trial. Eur J Heart Fail. 2012;14:931-38;
  2. Gheorghe, L. L Imaging for Native Mitral Valve Surgical and Transcatheter Interventions,JACC: Cardiovascular Imaging,Volume 14, Issue 1,2021,Pages 112-127,ISSN 1936-878X,
  3. Giallauria, F. et al. “Individual patient data meta-analysis of the effects of the CARILLON® mitral contour system.” ESC heart failure vol. 7,6 (2020): 3383-3391. doi:10.1002/ehf2.13125;
  4. Braemswig et al. Cerebral embolisation during transcatheter edge-to-edge repair of the mitral valve with the MitraClip system: a prospective, observational study. EuroIntervention 2022;18:e160-e168. DOI: 10.4244/EIJ-D-21-00646;
  5. O’Brien B. et al., Transseptal puncture — Review of anatomy, techniques, complications and challenges, Transseptal puncture—review of anatomy, techniques, complications and challenges. Int J Cardiol. (2017) 233:12–22. doi: 10.1016/j.ijcard.2017.02.009;
  6. Forlani D. et al, C34 INDIRECT MITRAL ANNULOPLASTY USING THE CARILLON CONTOUR SYSTEM, SINGLE CENTER EXPERIENCE, European Heart Journal Supplements, Volume 24, Issue Supplement_C, May 2022, suac011.033, https://doi.org/10.1093/eurheartj/suac011.033;
  7. Stark K., Massberg, S., Standards in Oral Anticoagulation after Percutaneous Valve Intervention, Aktuel Kardiol 2022; 11:477-483;
  8. Chhatriwalla AK, Vemulapalli S, Szerlip M, et al. Operator Experience and Outcomes of Transcatheter Mitral Valve Repair in the United States. J Am Coll Cardiol. 2019;74(24):2955-2965. doi:10.1016/j.jacc.2019.09.014
  9. Al-Azizi K, Szerlip M. Mitral Stenosis After MitraClip: How to Avoid and How to Treat. Curr Cardiol Rep. 2020;22(7):50. Published 2020 Jun 4. doi:10.1007/s11886-020-01301-5
  10. ESC Guidelines 2021;
  11. MitraClip IFU: EL2204011 (2020-07-22).;
  12. Witte KK et al. Treating symptoms and reversing remodelling: clinical and echocardiographic 1-year outcomes with percutaneous mitral annuloplasty for mild to moderate secondary mitral regurgitation. Eur J Heart Fail. 2021 Nov;23(11):1971-1978. doi: 10.1002/ejhf.2310. Epub 2021 Aug 4. PMID: 34288287;
  13. Anker, SD et al. “Percutaneous Mitral Valve Annuloplasty in Patients With Secondary Mitral Regurgitation and Severe Left Ventricular Enlargement.” JACC. Heart failure vol. 9,6 (2021): 453-462. doi:10.1016/j.jchf.2021.03.002;
  14. Stone, GW. A Randomized Trial of Transcatheter Mitral Valve Leaflet Approximation in Patients with Heart Failure and Secondary Mitral Regurgitation. Presented at TCT 2018. San Diego, CA..
  15. Witte KK et al. The REDUCE FMR Trial: A Randomized Sham-Controlled Study of Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation. JACC Heart Fail. 2019;7(11):945-955. doi:10.1016/j.jchf.2019.06.011;
  16. The Carillon Mitral Contour System® Instructions for Use Issue Date: 2023-07-27; Microsoft Word – LAB-1505-01AL (cardiacdimensions.com)
  17. Stone GW et al. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med. 2018 Dec 13;379(24):2307-2318. doi: 10.1056/NEJMoa1806640. Epub 2018 Sep 23. PMID: 30280640.
  18. Lipiecki J. et al. Coronary sinus-based percutaneous annuloplasty as treatment for functional mitral regurgitation: the TITAN II trial. BMJ Open Heart. 2016; 3: e000411;
  19. Obadia, Jean-François et al. “Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation.” The New England journal of medicine vol. 379,24 (2018): 2297-2306. doi:10.1056/NEJMoa1805374
  20. Rottländer,D. et al. Percutaneous Coronary Sinus–Based Mitral Valve Annuloplasty in Atrial Functional Mitral Regurgitation. J Am Coll Cardiol Intv. 2020 Dec, 13 (24) 2947–2949;

 

Cardiac Dimensions, Carillon and Carillon Mitral Contour System are registered trademarks of Cardiac Dimensions, Inc. The Carillon Mitral Contour System has received CE Mark approval (0344) and is available for sale in the European Union. CAUTION: The Carillon Mitral Contour System is limited to investigational use in the United States.

Join our mailing list for invitations to studies along with company announcements.

    Cardiac Dimensions logo - horizontal

    © 2023 Cardiac Dimensions. All rights reserved.

    *NOTE: The Carillon Mitral Contour System has received CE Mark (0344) and is available for sale in Europe and other countries that recognize CE Mark.

    CAUTION: Investigational Device. Limited by United States law to investigational use.

    Cardiac Dimensions logo - horizontal

    © 2022 Cardiac Dimensions. All rights reserved.

    *NOTE: The Carillon Mitral Contour System has received CE Mark (0344) and is available for sale in Europe and other countries that recognize CE Mark.

    CAUTION: Investigational Device. Limited by United States law to investigational use.